Objective To study the effect from the 79A C polymorphism in the (CDA) gene for the pharmacokinetics of gemcitabine and its own metabolite 2,2-difluorodeoxyuridine (dFdU) in non-small-cell lung tumor (NSCLC) individuals. 4C. The pellet was resuspended in 1?mL ice cool PBS. The rest of the suspension was used in a microcentrifuge glass and centrifuged quickly… Continue reading Objective To study the effect from the 79A C polymorphism in